Speciality: Oncology
Description:
A warm welcome to all the medical professionals in this crucial final discussion on the current scenario of cancer. The field of oncology is in the midst of a transformative era, driven by the profound importance of genomic testing and remarkable advancements in both diagnosis and treatment. In the past, cancer was often categorized by its anatomical location, leading to a "one-size-fits-all" approach. However, with the integration of cutting-edge technologies, we can now precisely identify the unique molecular and genetic drivers of each patient's tumor. This shift toward personalized medicine has enabled the development of highly effective targeted therapies and immunotherapies, which offer superior outcomes and fewer side effects compared to traditional cytotoxic chemotherapy.
The central pillar of this revolution is genomic testing, which provides a detailed blueprint of a tumor's genetic makeup. By identifying specific mutations, fusions, or other genomic alterations, clinicians can select treatments that directly target these abnormalities. This not only enhances therapeutic efficacy but also helps predict treatment resistance and informs clinical trial eligibility. Furthermore, advancements in diagnostic techniques, such as liquid biopsies and next-generation sequencing, are making it possible to detect cancer at earlier stages and monitor treatment response with unprecedented accuracy. This empowers healthcare providers to make more informed decisions, ensuring each patient receives the most appropriate and advanced care available.
Therefore, join Dr. Poonam Patil for this final discussion to gain a comprehensive understanding of how genomic testing is reshaping the current scenario of cancer care. Listen to the expert insights, grasp the shared knowledge on advancements in diagnosis and treatment, and continue to follow Hidoc for more such indispensable webinar sessions.
See More Webinars @ Hidoc Webinars
1.
AI-based liquid biopsy shows promise for detecting brain cancer
2.
Novel probes to label macrophages associated with cancer progression using a selective dye
3.
A Lot Can Be Said About You by Including Yourself in Photos.
4.
New methods show how fast breast cancers grow and how surgery delays affect cancer staging
5.
Telehealth in the pandemic era resulted in fewer therapy interruptions.
1.
The Benefits and Risks of Cervical Conization
2.
Impact of Hormone Therapy Cessation on Tumor Growth: Case Study of Ki-67 Reduction
3.
Case Study: Combining Targeted Therapy with Immunotherapy for Metastatic Melanoma
4.
The Immune Revolution: Neoantigen Vaccines and the Dawn of Personalized Cancer Therapy in 2025
5.
A New Hope: Exploring the Benefits of Exenteration for Cancer Patients
1.
International Lung Cancer Congress®
2.
Future NRG Oncology Meeting
3.
Genito-Urinary Oncology Summit 2026
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part III
2.
What Therapy Would Yield the Best Outcomes In Patients with R/R B-cell ALL?
3.
Rates of CR/CRi and MRD Negativity in Iontuzumab-Treated Patients
4.
Iron Deficiency Anemia: Ferric Maltol As a New Treatment Option- Summarization of the New Perspective
5.
Should We Use DARA Up Front As First-Line Therapy in MM? - Part II
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation